- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
According to our latest study, the global Oncolytic Virus market size was valued at USD 17 million in 2022 and is forecast to a readjusted size of USD 27 million by 2029 with a CAGR of 6.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
This report is a detailed and comprehensive analysis for global Oncolytic Virus market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oncolytic Virus market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oncolytic Virus market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oncolytic Virus market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Oncolytic Virus market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncolytic Virus
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncolytic Virus market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen and Shanghai Sunway Biotech.. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Oncolytic Virus market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Imlygic
Oncorine
Others
Market segment by Application
Melanoma
Other Cancers
Market segment by players, this report covers
Amgen
Shanghai Sunway Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncolytic Virus product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncolytic Virus, with revenue, gross margin and global market share of Oncolytic Virus from 2018 to 2023.
Chapter 3, the Oncolytic Virus competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oncolytic Virus market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncolytic Virus.
Chapter 13, to describe Oncolytic Virus research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Oncolytic Virus
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncolytic Virus by Type
1.3.1 Overview: Global Oncolytic Virus Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Oncolytic Virus Consumption Value Market Share by Type in 2022
1.3.3 Imlygic
1.3.4 Oncorine
1.3.5 Others
1.4 Global Oncolytic Virus Market by Application
1.4.1 Overview: Global Oncolytic Virus Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Melanoma
1.4.3 Other Cancers
1.5 Global Oncolytic Virus Market Size & Forecast
1.6 Global Oncolytic Virus Market Size and Forecast by Region
1.6.1 Global Oncolytic Virus Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Oncolytic Virus Market Size by Region, (2018-2029)
1.6.3 North America Oncolytic Virus Market Size and Prospect (2018-2029)
1.6.4 Europe Oncolytic Virus Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Oncolytic Virus Market Size and Prospect (2018-2029)
1.6.6 South America Oncolytic Virus Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Oncolytic Virus Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Oncolytic Virus Product and Solutions
2.1.4 Amgen Oncolytic Virus Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Shanghai Sunway Biotech
2.2.1 Shanghai Sunway Biotech Details
2.2.2 Shanghai Sunway Biotech Major Business
2.2.3 Shanghai Sunway Biotech Oncolytic Virus Product and Solutions
2.2.4 Shanghai Sunway Biotech Oncolytic Virus Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Shanghai Sunway Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oncolytic Virus Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Oncolytic Virus by Company Revenue
3.2.2 Top 3 Oncolytic Virus Players Market Share in 2022
3.2.3 Top 6 Oncolytic Virus Players Market Share in 2022
3.3 Oncolytic Virus Market: Overall Company Footprint Analysis
3.3.1 Oncolytic Virus Market: Region Footprint
3.3.2 Oncolytic Virus Market: Company Product Type Footprint
3.3.3 Oncolytic Virus Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Oncolytic Virus Consumption Value and Market Share by Type (2018-2023)
4.2 Global Oncolytic Virus Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Oncolytic Virus Consumption Value Market Share by Application (2018-2023)
5.2 Global Oncolytic Virus Market Forecast by Application (2024-2029)
6 North America
6.1 North America Oncolytic Virus Consumption Value by Type (2018-2029)
6.2 North America Oncolytic Virus Consumption Value by Application (2018-2029)
6.3 North America Oncolytic Virus Market Size by Country
6.3.1 North America Oncolytic Virus Consumption Value by Country (2018-2029)
6.3.2 United States Oncolytic Virus Market Size and Forecast (2018-2029)
6.3.3 Canada Oncolytic Virus Market Size and Forecast (2018-2029)
6.3.4 Mexico Oncolytic Virus Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Oncolytic Virus Consumption Value by Type (2018-2029)
7.2 Europe Oncolytic Virus Consumption Value by Application (2018-2029)
7.3 Europe Oncolytic Virus Market Size by Country
7.3.1 Europe Oncolytic Virus Consumption Value by Country (2018-2029)
7.3.2 Germany Oncolytic Virus Market Size and Forecast (2018-2029)
7.3.3 France Oncolytic Virus Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Oncolytic Virus Market Size and Forecast (2018-2029)
7.3.5 Russia Oncolytic Virus Market Size and Forecast (2018-2029)
7.3.6 Italy Oncolytic Virus Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Oncolytic Virus Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Oncolytic Virus Market Size by Region
8.3.1 Asia-Pacific Oncolytic Virus Consumption Value by Region (2018-2029)
8.3.2 China Oncolytic Virus Market Size and Forecast (2018-2029)
8.3.3 Japan Oncolytic Virus Market Size and Forecast (2018-2029)
8.3.4 South Korea Oncolytic Virus Market Size and Forecast (2018-2029)
8.3.5 India Oncolytic Virus Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Oncolytic Virus Market Size and Forecast (2018-2029)
8.3.7 Australia Oncolytic Virus Market Size and Forecast (2018-2029)
9 South America
9.1 South America Oncolytic Virus Consumption Value by Type (2018-2029)
9.2 South America Oncolytic Virus Consumption Value by Application (2018-2029)
9.3 South America Oncolytic Virus Market Size by Country
9.3.1 South America Oncolytic Virus Consumption Value by Country (2018-2029)
9.3.2 Brazil Oncolytic Virus Market Size and Forecast (2018-2029)
9.3.3 Argentina Oncolytic Virus Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Oncolytic Virus Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Oncolytic Virus Market Size by Country
10.3.1 Middle East & Africa Oncolytic Virus Consumption Value by Country (2018-2029)
10.3.2 Turkey Oncolytic Virus Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Oncolytic Virus Market Size and Forecast (2018-2029)
10.3.4 UAE Oncolytic Virus Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Oncolytic Virus Market Drivers
11.2 Oncolytic Virus Market Restraints
11.3 Oncolytic Virus Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Oncolytic Virus Industry Chain
12.2 Oncolytic Virus Upstream Analysis
12.3 Oncolytic Virus Midstream Analysis
12.4 Oncolytic Virus Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Oncolytic Virus Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oncolytic Virus Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Oncolytic Virus Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Oncolytic Virus Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Amgen Company Information, Head Office, and Major Competitors
Table 6. Amgen Major Business
Table 7. Amgen Oncolytic Virus Product and Solutions
Table 8. Amgen Oncolytic Virus Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Amgen Recent Developments and Future Plans
Table 10. Shanghai Sunway Biotech Company Information, Head Office, and Major Competitors
Table 11. Shanghai Sunway Biotech Major Business
Table 12. Shanghai Sunway Biotech Oncolytic Virus Product and Solutions
Table 13. Shanghai Sunway Biotech Oncolytic Virus Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Shanghai Sunway Biotech Recent Developments and Future Plans
Table 15. Global Oncolytic Virus Revenue (USD Million) by Players (2018-2023)
Table 16. Global Oncolytic Virus Revenue Share by Players (2018-2023)
Table 17. Breakdown of Oncolytic Virus by Company Type (Tier 1, Tier 2, and Tier 3)
Table 18. Market Position of Players in Oncolytic Virus, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 19. Head Office of Key Oncolytic Virus Players
Table 20. Oncolytic Virus Market: Company Product Type Footprint
Table 21. Oncolytic Virus Market: Company Product Application Footprint
Table 22. Oncolytic Virus New Market Entrants and Barriers to Market Entry
Table 23. Oncolytic Virus Mergers, Acquisition, Agreements, and Collaborations
Table 24. Global Oncolytic Virus Consumption Value (USD Million) by Type (2018-2023)
Table 25. Global Oncolytic Virus Consumption Value Share by Type (2018-2023)
Table 26. Global Oncolytic Virus Consumption Value Forecast by Type (2024-2029)
Table 27. Global Oncolytic Virus Consumption Value by Application (2018-2023)
Table 28. Global Oncolytic Virus Consumption Value Forecast by Application (2024-2029)
Table 29. North America Oncolytic Virus Consumption Value by Type (2018-2023) & (USD Million)
Table 30. North America Oncolytic Virus Consumption Value by Type (2024-2029) & (USD Million)
Table 31. North America Oncolytic Virus Consumption Value by Application (2018-2023) & (USD Million)
Table 32. North America Oncolytic Virus Consumption Value by Application (2024-2029) & (USD Million)
Table 33. North America Oncolytic Virus Consumption Value by Country (2018-2023) & (USD Million)
Table 34. North America Oncolytic Virus Consumption Value by Country (2024-2029) & (USD Million)
Table 35. Europe Oncolytic Virus Consumption Value by Type (2018-2023) & (USD Million)
Table 36. Europe Oncolytic Virus Consumption Value by Type (2024-2029) & (USD Million)
Table 37. Europe Oncolytic Virus Consumption Value by Application (2018-2023) & (USD Million)
Table 38. Europe Oncolytic Virus Consumption Value by Application (2024-2029) & (USD Million)
Table 39. Europe Oncolytic Virus Consumption Value by Country (2018-2023) & (USD Million)
Table 40. Europe Oncolytic Virus Consumption Value by Country (2024-2029) & (USD Million)
Table 41. Asia-Pacific Oncolytic Virus Consumption Value by Type (2018-2023) & (USD Million)
Table 42. Asia-Pacific Oncolytic Virus Consumption Value by Type (2024-2029) & (USD Million)
Table 43. Asia-Pacific Oncolytic Virus Consumption Value by Application (2018-2023) & (USD Million)
Table 44. Asia-Pacific Oncolytic Virus Consumption Value by Application (2024-2029) & (USD Million)
Table 45. Asia-Pacific Oncolytic Virus Consumption Value by Region (2018-2023) & (USD Million)
Table 46. Asia-Pacific Oncolytic Virus Consumption Value by Region (2024-2029) & (USD Million)
Table 47. South America Oncolytic Virus Consumption Value by Type (2018-2023) & (USD Million)
Table 48. South America Oncolytic Virus Consumption Value by Type (2024-2029) & (USD Million)
Table 49. South America Oncolytic Virus Consumption Value by Application (2018-2023) & (USD Million)
Table 50. South America Oncolytic Virus Consumption Value by Application (2024-2029) & (USD Million)
Table 51. South America Oncolytic Virus Consumption Value by Country (2018-2023) & (USD Million)
Table 52. South America Oncolytic Virus Consumption Value by Country (2024-2029) & (USD Million)
Table 53. Middle East & Africa Oncolytic Virus Consumption Value by Type (2018-2023) & (USD Million)
Table 54. Middle East & Africa Oncolytic Virus Consumption Value by Type (2024-2029) & (USD Million)
Table 55. Middle East & Africa Oncolytic Virus Consumption Value by Application (2018-2023) & (USD Million)
Table 56. Middle East & Africa Oncolytic Virus Consumption Value by Application (2024-2029) & (USD Million)
Table 57. Middle East & Africa Oncolytic Virus Consumption Value by Country (2018-2023) & (USD Million)
Table 58. Middle East & Africa Oncolytic Virus Consumption Value by Country (2024-2029) & (USD Million)
Table 59. Oncolytic Virus Raw Material
Table 60. Key Suppliers of Oncolytic Virus Raw Materials
List of Figures
Figure 1. Oncolytic Virus Picture
Figure 2. Global Oncolytic Virus Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oncolytic Virus Consumption Value Market Share by Type in 2022
Figure 4. Imlygic
Figure 5. Oncorine
Figure 6. Others
Figure 7. Global Oncolytic Virus Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Oncolytic Virus Consumption Value Market Share by Application in 2022
Figure 9. Melanoma Picture
Figure 10. Other Cancers Picture
Figure 11. Global Oncolytic Virus Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Oncolytic Virus Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Oncolytic Virus Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Oncolytic Virus Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Oncolytic Virus Consumption Value Market Share by Region in 2022
Figure 16. North America Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Oncolytic Virus Revenue Share by Players in 2022
Figure 22. Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Oncolytic Virus Market Share in 2022
Figure 24. Global Top 6 Players Oncolytic Virus Market Share in 2022
Figure 25. Global Oncolytic Virus Consumption Value Share by Type (2018-2023)
Figure 26. Global Oncolytic Virus Market Share Forecast by Type (2024-2029)
Figure 27. Global Oncolytic Virus Consumption Value Share by Application (2018-2023)
Figure 28. Global Oncolytic Virus Market Share Forecast by Application (2024-2029)
Figure 29. North America Oncolytic Virus Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Oncolytic Virus Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Oncolytic Virus Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Oncolytic Virus Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Oncolytic Virus Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Oncolytic Virus Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 39. France Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Oncolytic Virus Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Oncolytic Virus Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Oncolytic Virus Consumption Value Market Share by Region (2018-2029)
Figure 46. China Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 49. India Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Oncolytic Virus Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Oncolytic Virus Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Oncolytic Virus Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Oncolytic Virus Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Oncolytic Virus Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Oncolytic Virus Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Oncolytic Virus Consumption Value (2018-2029) & (USD Million)
Figure 63. Oncolytic Virus Market Drivers
Figure 64. Oncolytic Virus Market Restraints
Figure 65. Oncolytic Virus Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Oncolytic Virus in 2022
Figure 68. Manufacturing Process Analysis of Oncolytic Virus
Figure 69. Oncolytic Virus Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
